Board of Directors
Cindy M.L. Hutnik, BSc, MD, PhD, FRCSC
Honours BSc, MD, PhD, FRCSC, Diplomate of American Board of Ophthalmology
Associate Professor, Depts of Ophthalmology and Pathology, Univ of Western Ontario
Adjunct Professor, Dept of Chemistry & Biochemistry, Univ. of Windsor
Associate Scientist, Advanced Surgical Technologies, LHRI
Dr. Hutnik is a full professor in the Departments of Ophthalmology and Pathology at the Schulich School of Medicine and Dentistry. She is Chair of Research in the department and Director of the Ophthalmology Basic Science Laboratory at the Lawson Health Research Institute in the Center for Clinical Investigation and Therapeutics.
Dr. Hutnik earned her doctoral degree at the National Research Council followed by undergraduate medical training, both in Ottawa, Canada. She then obtained her ophthalmology training at the University of Western Ontario, in London, Canada followed by subspecialty glaucoma training under the mentorship of Dr. Paul Kaufman at the University of Wisconsin, Madison, USA.
Dr. Hutnik is currently a member of a number of editorial and research review boards. She supervises an independent program of clinical, basic science, educational research and collaborates with local colleagues engaged in health economics research. Her administrative roles have included Faculty Chair of the Summer Research Training Program at the University of Western Ontario, as well as membership on the Faculty Clinician-Scientist committee, medical advisory committee of the Canadian National Institute for the Blind Mobile Eye Care Programme and currently is a councilor of the Canadian Glaucoma Society.
Dr. Hutnik’s major research interest is focused on the pathophysiology and management of glaucoma with a sub-interest in ocular surface and macular disease. She has supervised and mentored in research more than 150 students at all levels of training ranging from high school to graduate science and medicine. Her work has been presented and published both nationally and internationally and has been recognized with over 60 awards. She continues to have keen interest in the development of novel and/or optimization of existing treatments for patients with glaucoma.
In addition to research, she is engaged in a number of initiatives such as creation of a multi-discipline low vision rehabilitation center in London, collaborative models of dissemination of the Canadian Glaucoma Guidelines and global partnerships in eye care between the Schulich School and key centers in China.